Exosome RNA Exosome RNA Research & Industry News
Biofluids consist of circulating tumor cells (CTCs), cell-free nucleic acid (cfNA), or extracellular vesicles (EVs) from multiple tissues or infectious agents within the body. Rapid developments of highly sensitive and accurate analytical tools have allowed analysis of the role of these biomarkers in health, disease, and treatment response leading to targeted therapies. However, there still remains insecurity associated with biofluid-based DNA/RNA analytical methods, which must be solved before liquid biopsies can be implemented for broader routine clinical applications.
Join leading researchers from around the world at the 4th Annual Liquid Biopsy Summit to discuss process and technology refinements that will enable molecular liquid biopsies to become a fulcrum in the future of precision medicine.
